Willis Investment Counsel’s AbbVie ABBV Stock Holding History

Willis Investment Counsel’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$210K	Sell	964 -100	-9%	-$22.2K	0.01%	119
2025 Q4	$243K	Sell	1,064 -125	-11%	-$28.5K	0.01%	121
2025 Q3	$275K	Buy	1,189 +48	+4%	+$9.78K	0.02%	114
2025 Q2	$212K	Hold	1,141	–	–	0.01%	115
2025 Q1	$239K	Sell	1,141 -13	-1%	-$2.53K	0.02%	109
2024 Q4	$205K	Buy	1,154 +13	+1%	+$2.39K	0.01%	113
2024 Q3	$225K	Buy	+1,141	New	+$213K	0.01%	109
2024 Q2	–	Sell	-1,141	Closed	-$208K	–	108
2024 Q1	$208K	Buy	+1,141	New	+$197K	0.01%	104
2023 Q2	–	Sell	-1,294	Closed	-$206K	–	111
2023 Q1	$206K	Buy	+1,294	New	+$198K	0.01%	107

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Willis Investment Counsel's ABBV Position: Q1 2026 in Review

Willis Investment Counsel reduced its AbbVie (ABBV) stake by 9.4% in Q1 2026, selling an estimated $22.2K and leaving 964 shares worth $210K. The position accounts for 0.01% of the portfolio, ranked #119.

Willis Investment Counsel first reported a position in ABBV in Q1 2023 and has held it in 9 quarters since. The position peaked at $275K in Q3 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Willis Investment Counsel held 964 shares of AbbVie worth $210K as of Q1 2026.
Willis Investment Counsel sold 100 AbbVie shares in Q1 2026, an estimated $22.2K.
AbbVie made up 0.01% of Willis Investment Counsel's portfolio in Q1 2026, its #119 holding.
Willis Investment Counsel first reported a position in AbbVie in Q1 2023 and has held it in 9 quarters since.
Willis Investment Counsel's AbbVie position peaked at $275K in Q3 2025.
4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Willis Investment Counsel's 13F filing for Q1 2026, filed 5 May 2026.